This was maybe due to a more severe burden of comorbidities in the supplemented patients (a higher proportion suffered from COPD and their Hb levels were lower, Table 2), even if the HF severity was similar. The gene discussed is GSTM1; the disease is chronic obstructive pulmonary disease.